{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T21:46:55Z","timestamp":1794779215100,"version":"4.9.1"},"reference-count":103,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2020,3,27]]},"abstract":"<jats:sec><jats:title\/><jats:p>Matrix Gla protein (MGP) is a vitamin K-dependent protein, which is synthesized in bone and many other mesenchymal cells, which is also highly expressed by vascular smooth muscle cells (VSMCs) and chondrocytes. Numerous studies have confirmed that MGP acts as a calcification-inhibitor although the mechanism of action is still not fully understood. The modulation of tissue calcification by MGP is potentially regulated in several ways including direct inhibition of calcium-phosphate precipitation, the formation of matrix vesicles (MVs), the formation of apoptotic bodies (ABs), and trans-differentiation of VSMCs. MGP occurs as four species, i.e. fully carboxylated (cMGP), under-carboxylated, i.e. poorly carboxylated (ucMGP), phosphorylated (pMGP), and non-phosphorylated (desphospho, dpMGP). ELISA methods are currently available that can detect the different species of MGP. The expression of the MGP gene can be regulated via various mechanisms that have the potential to become genomic biomarkers for the prediction of vascular calcification (VC) progression. VC is an established risk factor for cardiovascular disease and is particularly prevalent in those with chronic kidney disease (CKD). The specific action of MGP is not yet clearly understood but could be involved with the functional inhibition of BMP-2 and BMP-4, by blocking calcium crystal deposition and shielding the nidus from calcification.<\/jats:p><\/jats:sec>","DOI":"10.2174\/0929867325666180716104159","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T11:35:18Z","timestamp":1562326518000},"page":"1647-1660","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["The Role of Matrix Gla Protein (MGP) in Vascular Calcification"],"prefix":"10.2174","volume":"27","author":[{"given":"Geir","family":"Bj\u00f8rklund","sequence":"first","affiliation":[{"name":"Council for Nutritional and Environmental Medicine, Mo i Rana, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Svanberg","sequence":"additional","affiliation":[{"name":"Department of Medicine, Solleftea Hospital, Solleftea, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Dadar","sequence":"additional","affiliation":[{"name":"Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Card","sequence":"additional","affiliation":[{"name":"Human Nutristasis Unit, Viapath, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Chirumbolo","sequence":"additional","affiliation":[{"name":"Department of Neurological and Movement Sciences, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic J.","family":"Harrington","sequence":"additional","affiliation":[{"name":"Human Nutristasis Unit, Viapath, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Aaseth","sequence":"additional","affiliation":[{"name":"Department of Research, Innlandet Hospital Trust, Brumunddal, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","volume":"383","author":"Mahmood S.S.","year":"2014","unstructured":"Mahmood S.S.; Levy D.; Vasan R.S.; Wang T.J.; The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet 2014,383(9921),999-1008","journal-title":"Lancet"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/VHRM.S4822","volume":"5","author":"Rennenberg R.J.","year":"2009","unstructured":"Rennenberg R.J.; Kessels A.G.; Schurgers L.J.; van Engelshoven J.M.; de Leeuw P.W.; Kroon A.A.; Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag 2009,5(1),185-197","journal-title":"Vasc Health Risk Manag"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000380980","volume":"Vol. 185","author":"Nitta K.","year":"2015","unstructured":"Nitta K.; Ogawa T.; Vascular calcification in end-stage renal disease patients in: Chronic Kidney Diseases-Recent Advances in Clinical and Basic Research 2015,Vol. 185,156-167","journal-title":"Vascular calcification in end-stage renal disease patients in: Chronic Kidney Diseases-Recent Advances in Clinical and Basic Research"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s11914-015-0293-9","volume":"13","author":"Chen N.X.","year":"2015","unstructured":"Chen N.X.; Moe S.M.; Pathophysiology of vascular calcification. Curr Osteoporos Rep 2015,13(6),372-380","journal-title":"Curr Osteoporos Rep"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cca.2014.08.034","volume":"438","author":"Evrard S.","year":"2015","unstructured":"Evrard S.; Delanaye P.; Kamel S.; Cristol J-P.; Cavalier E.; Arnaud J.; Zaoui P.; Carlier M.; Laville M.; Fouque D.; Vascular calcification: from pathophysiology to biomarkers. Clin Chim Acta 2015,438,401-414","journal-title":"Clin Chim Acta"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/01.rli.0000233325.42572.08","volume":"41","author":"Pham P.H.","year":"2006","unstructured":"Pham P.H.; Rao D.S.; Vasunilashorn F.; Fishbein M.C.; Goldin J.G.; Computed tomography calcium quantification as a measure of atherosclerotic plaque morphology and stability. Invest Radiol 2006,41(9),674-680","journal-title":"Invest Radiol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"668","DOI":"10.11909\/j.issn.1671-5411.2015.06.012","volume":"12","author":"Liu W.","year":"2015","unstructured":"Liu W.; Zhang Y.; Yu C-M.; Ji Q-W.; Cai M.; Zhao Y-X.; Zhou Y-J.; Current understanding of coronary artery calcification. J Geriatr Cardiol 2015,12(6),668-675","journal-title":"J Geriatr Cardiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"8335","DOI":"10.1073\/pnas.84.23.8335","volume":"84","author":"Price P.A.","year":"1987","unstructured":"Price P.A.; Fraser J.D.; Metz-Virca G.; Molecular cloning of matrix Gla protein: implications for substrate recognition by the vitamin K-dependent gamma-carboxylase. Proc Natl Acad Sci USA 1987,84(23),8335-8339","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1160\/TH08-02-0087","volume":"100","author":"Schurgers L.J.","year":"2008","unstructured":"Schurgers L.J.; Cranenburg E.C.; Vermeer C.; Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost 2008,100(4),593-603","journal-title":"Thromb Haemost"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/ATVBAHA.114.304823","volume":"35","author":"Viegas C.S.","year":"2015","unstructured":"Viegas C.S.; Rafael M.S.; Enriquez J.L.; Teixeira A.; Vitorino R.; Lu\u00eds I.M.; Costa R.M.; Santos S.; Cavaco S.; Neves J.; Macedo A.L.; Willems B.A.; Vermeer C.; Simes D.C.; Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system. Arterioscler Thromb Vasc Biol 2015,35(2),399-408","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1681\/ASN.2008070692","volume":"20","author":"Mizobuchi M.","year":"2009","unstructured":"Mizobuchi M.; Towler D.; Slatopolsky E.; Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 2009,20(7),1453-1464","journal-title":"J Am Soc Nephrol"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151499","volume":"11","author":"Horn P.","year":"2016","unstructured":"Horn P.; Erkilet G.; Veulemans V.; Kr\u00f6pil P.; Schurgers L.; Zeus T.; Heiss C.; Kelm M.; Westenfeld R.; Microparticle-induced coagulation relates to coronary artery atherosclerosis in severe aortic valve stenosis. PLoS One 2016,11(3)","journal-title":"PLoS One"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.biochi.2015.09.008","volume":"118","author":"Jarray R.","year":"2015","unstructured":"Jarray R.; Pavoni S.; Borriello L.; Allain B.; Lopez N.; Bianco S.; Liu W-Q.; Biard D.; Demange L.; Hermine O.; Garbay C.; Raynaud F.; Lepelletier Y.; Disruption of phactr-1 pathway triggers pro-inflammatory and pro-atherogenic factors: New insights in atherosclerosis development. Biochimie 2015,118,151-161","journal-title":"Biochimie"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11010-017-3023-z","volume":"433","author":"Qiu C.","year":"2017","unstructured":"Qiu C.; Zheng H.; Tao H.; Yu W.; Jiang X.; Li A.; Jin H.; Lv A.; Li H.; Vitamin K2 inhibits rat vascular smooth muscle cell calcification by restoring the Gas6\/Axl\/Akt anti-apoptotic pathway. Mol Cell Biochem 2017,433(1-2),149-159","journal-title":"Mol Cell Biochem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.diabres.2010.08.019","volume":"92","author":"Reyes Garc\u00eda R.","year":"2011","unstructured":"Reyes Garc\u00eda R.; Rozas Moreno P.; Mu\u00f1oz-Torres M.; Osteocalcin and atherosclerosis: a complex relationship. Diabetes Res Clin Pract 2011,92(3),405-406","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1161\/ATVBAHA.115.306397","volume":"36","author":"Schwanekamp J.A.","year":"2016","unstructured":"Schwanekamp J.A.; Lorts A.; Vagnozzi R.J.; Vanhoutte D.; Molkentin J.D.; Deletion of periostin protects against atherosclerosis in mice by altering inflammation and extracellular matrix remodeling. Arterioscler Thromb Vasc Biol 2016,36(1),60-68","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/ATVBAHA.112.300491","volume":"33","author":"Cassidy-Bushrow A.E.","year":"2013","unstructured":"Cassidy-Bushrow A.E.; Bielak L.F.; Levin A.M.; Sheedy P.F.; Turner S.T.; Boerwinkle E.; Lin X.; Kardia S.L.; Peyser P.A.; Matrix gla protein gene polymorphism is associated with increased coronary artery calcification progression. Arterioscler Thromb Vasc Biol 2013,33(3),645-651","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1161\/01.ATV.20.11.2386","volume":"20","author":"Herrmann S-M.","year":"2000","unstructured":"Herrmann S-M.; Whatling C.; Brand E.; Nicaud V.; Gariepy J.; Simon A.; Evans A.; Ruidavets J-B.; Arveiler D.; Luc G.; Tiret L.; Henney A.; Cambien F.; Polymorphisms of the human matrix gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler Thromb Vasc Biol 2000,20(11),2386-2393","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1681\/ASN.2007080854","volume":"19","author":"Moe S.M.","year":"2008","unstructured":"Moe S.M.; Chen N.X.; Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 2008,19(2),213-216","journal-title":"J Am Soc Nephrol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1053\/j.ajkd.2003.12.005","volume":"43","author":"Goodman W.G.","year":"2004","unstructured":"Goodman W.G.; London G.; Amann K.; Block G.A.; Giachelli C.; Hruska K.A.; Ketteler M.; Levin A.; Massy Z.; McCarron D.A.; Raggi P.; Shanahan C.M.; Yorioka N.; Vascular calcification in chronic kidney disease. Am J Kidney Dis 2004,43(3),572-579","journal-title":"Am J Kidney Dis"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s00774-005-0668-6","volume":"24","author":"Jono S.","year":"2006","unstructured":"Jono S.; Shioi A.; Ikari Y.; Nishizawa Y.; Vascular calcification in chronic kidney disease. J Bone Miner Metab 2006,24(2),176-181","journal-title":"J Bone Miner Metab"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.clnu.2014.03.011","volume":"34","author":"Cheung C-L.","year":"2015","unstructured":"Cheung C-L.; Sahni S.; Cheung B.M.; Sing C-W.; Wong I.C.; Vitamin K intake and mortality in people with chronic kidney disease from NHANES III. Clin Nutr 2015,34(2),235-240","journal-title":"Clin Nutr"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1194\/jlr.R045559","volume":"55","author":"Shearer M.J.","year":"2014","unstructured":"Shearer M.J.; Newman P.; Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis. J Lipid Res 2014,55(3),345-362","journal-title":"J Lipid Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/mnfr.201300683","volume":"58","author":"Card D.J.","year":"2014","unstructured":"Card D.J.; Gorska R.; Cutler J.; Harrington D.J.; Vitamin K metabolism: current knowledge and future research. Mol Nutr Food Res 2014,58(8),1590-1600","journal-title":"Mol Nutr Food Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1194\/jlr.D400033-JLR200","volume":"46","author":"Harrington D.J.","year":"2005","unstructured":"Harrington D.J.; Soper R.; Edwards C.; Savidge G.F.; Hodges S.J.; Shearer M.J.; Determination of the urinary aglycone metabolites of vitamin K by HPLC with redox-mode electrochemical detection. J Lipid Res 2005,46(5),1053-1060","journal-title":"J Lipid Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/bmc.1250","volume":"23","author":"Card D.J.","year":"2009","unstructured":"Card D.J.; Shearer M.J.; Schurgers L.J.; Harrington D.J.; The external quality assurance of phylloquinone (vitamin K(1)) analysis in human serum. Biomed Chromatogr 2009,23(12),1276-1282","journal-title":"Biomed Chromatogr"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0021-9258(19)35439-0","volume":"263","author":"Fraser J.D.","year":"1988","unstructured":"Fraser J.D.; Otawara Y.; Price P.A.; 1,25-Dihydroxyvitamin D3 stimulates the synthesis of matrix gamma-carboxyglutamic acid protein by osteosarcoma cells. Mutually exclusive expression of vitamin K-dependent bone proteins by clonal osteoblastic cell lines. J Biol Chem 1988,263(2),911-916","journal-title":"J Biol Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1359\/jbmr.2001.16.9.1611","volume":"16","author":"Cancela M.L.","year":"2001","unstructured":"Cancela M.L.; Ohresser M.C.; Reia J.P.; Viegas C.S.; Williamson M.K.; Price P.A.; Matrix Gla protein in Xenopus laevis: molecular cloning, tissue distribution, and evolutionary considerations. J Bone Miner Res 2001,16(9),1611-1621","journal-title":"J Bone Miner Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.lfs.2016.12.011","volume":"172","author":"Ahmad S.","year":"2017","unstructured":"Ahmad S.; Jan A.T.; Baig M.H.; Lee E.J.; Choi I.; Matrix gla protein: An extracellular matrix protein regulates myostatin expression in the muscle developmental program. Life Sci 2017,172,55-63","journal-title":"Life Sci"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"15040","DOI":"10.1016\/S0021-9258(18)77221-9","volume":"265","author":"Cancela L.","year":"1990","unstructured":"Cancela L.; Hsieh C.L.; Francke U.; Price P.A.; Molecular structure, chromosome assignment, and promoter organization of the human matrix Gla protein gene. J Biol Chem 1990,265(25),15040-15048","journal-title":"J Biol Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1073\/pnas.94.6.2227","volume":"94","author":"Kirfel J.","year":"1997","unstructured":"Kirfel J.; Kelter M.; Cancela L.M.; Price P.A.; Sch\u00fcle R.; Identification of a novel negative retinoic acid responsive element in the promoter of the human matrix Gla protein gene. Proc Natl Acad Sci USA 1997,94(6),2227-2232","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=32","first-page":"69","volume":"50","author":"Kobayashi N.","year":"2004","unstructured":"Kobayashi N.; Kitazawa R.; Maeda S.; Schurgers L.; Kitazawa S.; T-138C polymorphism of matrix gla protein promoter alters its expression but is not directly associated with atherosclerotic vascular calcification. Kobe J Med Sci 2004,50(3-4),69-81","journal-title":"Kobe J Med Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.archoralbio.2016.06.014","volume":"70","author":"Do\u011fan G.E.","year":"2016","unstructured":"Do\u011fan G.E.; Demir T.; Aksoy H.; Sa\u011flam E.; Lalo\u011flu E.; Yildirim A.; Matrix-Gla Protein rs4236 [A\/G] gene polymorphism and serum and GCF levels of MGP in patients with subgingival dental calculus. Arch Oral Biol 2016,70,125-129","journal-title":"Arch Oral Biol"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"14971","DOI":"10.1016\/S0021-9258(18)95688-7","volume":"260","author":"Price P.A.","year":"1985","unstructured":"Price P.A.; Williamson M.K.; Primary structure of bovine matrix Gla protein, a new vitamin K-dependent bone protein. J Biol Chem 1985,260(28),14971-14975","journal-title":"J Biol Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1681\/ASN.2016060651","volume":"28","author":"Nigwekar S.U.","year":"2017","unstructured":"Nigwekar S.U.; Bloch D.B.; Nazarian R.M.; Vermeer C.; Booth S.L.; Xu D.; Thadhani R.I.; Malhotra R.; Vitamin K\u2013dependent carboxylation of matrix Gla protein influences the risk of calciphylaxis. J Am Soc Nephrol 2017,28(6),1717-1722","journal-title":"J Am Soc Nephrol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S8756-3282(02)00821-9","volume":"31","author":"Roy M.E.","year":"2002","unstructured":"Roy M.E.; Nishimoto S.K.; Matrix Gla protein binding to hydroxyapatite is dependent on the ionic environment: calcium enhances binding affinity but phosphate and magnesium decrease affinity. Bone 2002,31(2),296-302","journal-title":"Bone"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.molmed.2012.12.008","volume":"19","author":"Schurgers L.J.","year":"2013","unstructured":"Schurgers L.J.; Uitto J.; Reutelingsperger C.P.; Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med 2013,19(4),217-226","journal-title":"Trends Mol Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1083\/jcb.200402046","volume":"165","author":"Murshed M.","year":"2004","unstructured":"Murshed M.; Schinke T.; McKee M.D.; Karsenty G.; Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol 2004,165(5),625-630","journal-title":"J Cell Biol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/0006-291X(83)91663-7","volume":"117","author":"Price P.A.","year":"1983","unstructured":"Price P.A.; Urist M.R.; Otawara Y.; Matrix Gla protein, a new \u03b3-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun 1983,117(3),765-771","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=40","author":"Shanahan C.M.","year":"2015","unstructured":"Shanahan C.M.; Kapustin A.N.; Google Patents 2015","journal-title":"Google Patents"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"22153","DOI":"10.1074\/jbc.M300739200","volume":"278","author":"Price P.A.","year":"2003","unstructured":"Price P.A.; Nguyen T.M.T.; Williamson M.K.; Biochemical characterization of the serum fetuin-mineral complex. J Biol Chem 2003,278(24),22153-22160","journal-title":"J Biol Chem"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1055\/s-0037-1614168","volume":"84","author":"Wallin R.","year":"2000","unstructured":"Wallin R.; Cain D.; Hutson S.M.; Sane D.C.; Loeser R.; Modulation of the binding of matrix Gla protein (MGP) to bone morphogenetic protein-2 (BMP-2). Thromb Haemost 2000,84(6),1039-1044","journal-title":"Thromb Haemost"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1074\/jbc.M109683200","volume":"277","author":"Zebboudj A.F.","year":"2002","unstructured":"Zebboudj A.F.; Imura M.; Bostr\u00f6m K.; Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem 2002,277(6),4388-4394","journal-title":"J Biol Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/386078a0","volume":"386","author":"Luo G.","year":"1997","unstructured":"Luo G.; Ducy P.; McKee M.D.; Pinero G.J.; Loyer E.; Behringer R.R.; Karsenty G.; Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997,386(6620),78-81","journal-title":"Nature"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1126\/science.1749935","volume":"254","author":"Wu S-M.","year":"1991","unstructured":"Wu S-M.; Cheung W-F.; Frazier D.; Stafford D.W.; Cloning and expression of the cDNA for human gamma-glutamyl carboxylase. Science 1991,254(5038),1634-1636","journal-title":"Science"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1182\/blood.V88.7.2585.bloodjournal8872585","volume":"88","author":"Bristol J.A.","year":"1996","unstructured":"Bristol J.A.; Ratcliffe J.V.; Roth D.A.; Jacobs M.A.; Furie B.C.; Furie B.; Biosynthesis of prothrombin: intracellular localization of the vitamin K-dependent carboxylase and the sites of gamma-carboxylation. Blood 1996,88(7),2585-2593","journal-title":"Blood"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/bjh.13828","volume":"174","author":"Card D.J.","year":"2016","unstructured":"Card D.J.; Shearer M.J.; Schurgers L.J.; Gomez K.; Harrington D.J.; What\u2019s in a name? The pharmacy of vitamin K. Br J Haematol 2016,174(6),989-990","journal-title":"Br J Haematol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1079\/BJN19940043","volume":"72","author":"Thijssen H.H.","year":"1994","unstructured":"Thijssen H.H.; Drittij-Reijnders M.J.; Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4. Br J Nutr 1994,72(3),415-425","journal-title":"Br J Nutr"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jphotobiol.2016.11.016","volume":"166","author":"Suganthi M.","year":"2017","unstructured":"Suganthi M.; Elango K.P.; Synthesis, characterization and serum albumin binding studies of vitamin K3 derivatives. J Photochem Photobiol B 2017,166,126-135","journal-title":"J Photochem Photobiol B"},{"key":"ref=50","first-page":"915","volume":"89","author":"Conly J.M.","year":"1994","unstructured":"Conly J.M.; Stein K.; Worobetz L.; Rutledge-Harding S.; The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am J Gastroenterol 1994,89(6),915-923","journal-title":"Am J Gastroenterol"},{"key":"ref=51","doi-asserted-by":"publisher","DOI":"10.5772\/63712","author":"Walther B.","year":"2017","unstructured":"Walther B.; Chollet M.; Menaquinones, bacteria, and foods: vitamin K2 in the diet in: Vitamin K2-vital for health and wellbeing 2017","journal-title":"Menaquinones, bacteria, and foods: vitamin K2 in the diet in: Vitamin K2-vital for health and wellbeing"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"25276","DOI":"10.1074\/jbc.M401645200","volume":"279","author":"Wajih N.","year":"2004","unstructured":"Wajih N.; Sane D.C.; Hutson S.M.; Wallin R.; The inhibitory effect of calumenin on the vitamin K-dependent \u03b3-carboxylation system. Characterization of the system in normal and warfarin-resistant rats. J Biol Chem 2004,279(24),25276-25283","journal-title":"J Biol Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1046\/j.1523-1755.63.s84.21.x","volume":"63","author":"Ketteler M.","year":"2003","unstructured":"Ketteler M.; Wanner C.; Metzger T.; Bongartz P.; Westenfeld R.; Gladziwa U.; Schurgers L.J.; Vermeer C.; Jahnen-Dechent W.; Floege J.; Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia. Kidney Int Suppl 2003,63(84),S84-S87","journal-title":"Kidney Int Suppl"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1172\/JCI117246","volume":"93","author":"Shanahan C.M.","year":"1994","unstructured":"Shanahan C.M.; Cary N.R.; Metcalfe J.C.; Weissberg P.L.; High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 1994,93(6),2393-2402","journal-title":"J Clin Invest"},{"key":"ref=55","first-page":"99","volume":"46","author":"Stehbens W.E.","year":"2000","unstructured":"Stehbens W.E.; The significance of programmed cell death or apoptosis and matrix vesicles in atherogenesis. Cell Mol Biol 2000,46(1),99-110","journal-title":"Cell Mol Biol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","volume":"15","author":"Reynolds J.L.","year":"2004","unstructured":"Reynolds J.L.; Joannides A.J.; Skepper J.N.; McNair R.; Schurgers L.J.; Proudfoot D.; Jahnen-Dechent W.; Weissberg P.L.; Shanahan C.M.; Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004,15(11),2857-2867","journal-title":"J Am Soc Nephrol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"43919","DOI":"10.1074\/jbc.M303136200","volume":"278","author":"Tabb M.M.","year":"2003","unstructured":"Tabb M.M.; Sun A.; Zhou C.; Gr\u00fcn F.; Errandi J.; Romero K.; Pham H.; Inoue S.; Mallick S.; Lin M.; Forman B.M.; Blumberg B.; Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 2003,278(45),43919-43927","journal-title":"J Biol Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1111\/j.1523-1755.2005.00333.x","volume":"67","author":"Moe S.M.","year":"2005","unstructured":"Moe S.M.; Reslerova M.; Ketteler M.; O\u2019neill K.; Duan D.; Koczman J.; Westenfeld R.; Jahnen-Dechent W.; Chen N.X.; Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 2005,67(6),2295-2304","journal-title":"Kidney Int"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s10157-013-0785-9","volume":"17","author":"Yoshikawa K.","year":"2013","unstructured":"Yoshikawa K.; Abe H.; Tominaga T.; Nakamura M.; Kishi S.; Matsuura M.; Nagai K.; Tsuchida K.; Minakuchi J.; Doi T.; Polymorphism in the human matrix Gla protein gene is associated with the progression of vascular calcification in maintenance hemodialysis patients. Clin Exp Nephrol 2013,17(6),882-889","journal-title":"Clin Exp Nephrol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"8713","DOI":"10.1038\/s41598-017-09328-5","volume":"7","author":"Sheng K.","year":"2017","unstructured":"Sheng K.; Zhang P.; Lin W.; Cheng J.; Li J.; Chen J.; Association of Matrix Gla protein gene (rs1800801, rs1800802, rs4236) polymorphism with vascular calcification and atherosclerotic disease: a meta-analysis. Sci Rep 2017,7(1),8713","journal-title":"Sci Rep"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1160\/TH09-11-0786","volume":"104","author":"Cranenburg E.C.","year":"2010","unstructured":"Cranenburg E.C.; Koos R.; Schurgers L.J.; Magdeleyns E.J.; Schoonbrood T.H.; Landew\u00e9 R.B.; Brandenburg V.M.; Bekers O.; Vermeer C.; Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost 2010,104(4),811-822","journal-title":"Thromb Haemost"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/ncpneph0601","volume":"3","author":"Holden R.M.","year":"2007","unstructured":"Holden R.M.; Booth S.L.; Vascular calcification in chronic kidney disease: the role of vitamin K. Nat Clin Pract Nephrol 2007,3(10),522-523","journal-title":"Nat Clin Pract Nephrol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.numecd.2008.10.004","volume":"19","author":"Gast G-C.M.","year":"2009","unstructured":"Gast G-C.M.; de Roos N.M.; Sluijs I.; Bots M.L.; Beulens J.W.; Geleijnse J.M.; Witteman J.C.; Grobbee D.E.; Peeters P.H.; van der Schouw Y.T.; A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis 2009,19(7),504-510","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1083\/jcb.147.5.1097","volume":"147","author":"Yagami K.","year":"1999","unstructured":"Yagami K.; Suh J-Y.; Enomoto-Iwamoto M.; Koyama E.; Abrams W.R.; Shapiro I.M.; Pacifici M.; Iwamoto M.; Matrix GLA protein is a developmental regulator of chondrocyte mineralization and, when constitutively expressed, blocks endochondral and intramembranous ossification in the limb. J Cell Biol 1999,147(5),1097-1108","journal-title":"J Cell Biol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.joca.2010.05.013","volume":"18","author":"Wallin R.","year":"2010","unstructured":"Wallin R.; Schurgers L.J.; Loeser R.F.; Biosynthesis of the vitamin K-dependent matrix Gla protein (MGP) in chondrocytes: a fetuin-MGP protein complex is assembled in vesicles shed from normal but not from osteoarthritic chondrocytes. Osteoarthritis Cartilage 2010,18(8),1096-1103","journal-title":"Osteoarthritis Cartilage"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/5102","volume":"21","author":"Munroe P.B.","year":"1999","unstructured":"Munroe P.B.; Olgunturk R.O.; Fryns J-P.; Van Maldergem L.; Ziereisen F.; Yuksel B.; Gardiner R.M.; Chung E.; Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet 1999,21(1),142-144","journal-title":"Nat Genet"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/ajmg.a.36390","volume":"164A","author":"Weaver K.N.","year":"2014","unstructured":"Weaver K.N.; El Hallek M.; Hopkin R.J.; Sund K.L.; Henrickson M.; Del Gaudio D.; Yuksel A.; Acar G.O.; Bober M.B.; Kim J.; Boyadjiev S.A.; Keutel syndrome: report of two novel MGP mutations and discussion of clinical overlap with arylsulfatase E deficiency and relapsing polychondritis. Am J Med Genet A 2014,164A(4),1062-1068","journal-title":"Am J Med Genet A"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/ajmg.a.30680","volume":"135","author":"Hur D.J.","year":"2005","unstructured":"Hur D.J.; Raymond G.V.; Kahler S.G.; Riegert-Johnson D.L.; Cohen B.A.; Boyadjiev S.A.; A novel MGP mutation in a consanguineous family: review of the clinical and molecular characteristics of Keutel syndrome. Am J Med Genet A 2005,135(1),36-40","journal-title":"Am J Med Genet A"},{"key":"ref=69","first-page":"527","volume":"51","author":"Sun L.F.","year":"2013","unstructured":"Sun L.F.; Ju Y.F.; Fu G.J.; Wang J.R.; Feng Y.Z.; Chen X.; [Keutel syndrome with tracheal stenosis as the major symptom: case report and literature review]. Zhonghua Er Ke Za Zhi 2013,51(7),527-530","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/978-94-007-7678-4_14","author":"Vermeer C.","year":"2015","unstructured":"Vermeer C.; Drummen N.E.; Knapen M.H.; Zandbergen F.J.; Uncarboxylated Matrix Gla Protein as a Biomarker in Cardiovascular Disease: Applications for Research and for Routine Diagnostics in 2015,267-283","journal-title":"Uncarboxylated Matrix Gla Protein as a Biomarker in Cardiovascular Disease: Applications for Research and for Routine Diagnostics in"},{"key":"ref=71","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22278","volume":"32","author":"Buyukterzi Z.","year":"2018","unstructured":"Buyukterzi Z.; Can U.; Alpaydin S.; Guzelant A.; Karaarslan S.; Mustu M.; Kocyigit D.; Gurses K.M.; Enhanced serum levels of matrix Gla protein and bone morphogenetic protein in acute coronary syndrome patients. J Clin Lab Anal 2018,32(3)","journal-title":"J Clin Lab Anal"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1515\/cclm.2011.713","volume":"50","author":"Silaghi C.N.","year":"2011","unstructured":"Silaghi C.N.; Fodor D.; Cristea V.; Cr\u0103ciun A.M.; Synovial and serum levels of uncarboxylated matrix Gla-protein (ucMGP) in patients with arthritis. Clin Chem Lab Med 2011,50(1),125-128","journal-title":"Clin Chem Lab Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1515\/cclm-2012-0329","volume":"51","author":"Silaghi C.N.","year":"2013","unstructured":"Silaghi C.N.; Fodor D.; Cr\u0103ciun A.M.; Circulating matrix Gla protein: a potential tool to identify minor carotid stenosis with calcification in a risk population. Clin Chem Lab Med 2013,51(5),1115-1123","journal-title":"Clin Chem Lab Med"},{"key":"ref=74","first-page":"65","volume":"7","author":"Silaghi C.N.","year":"2015","unstructured":"Silaghi C.N.; Olteanu G.; Cr\u0103ciun A.M.; The behavior of circulating matrix Gla protein, matrix metalloproteinase-9 and nitrotyrosine in patients with varicose veins. Human and Veterinary Medicine 2015,7(2),65-69","journal-title":"Human and Veterinary Medicine"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.2215\/CJN.01930408","volume":"3","author":"McCullough P.A.","year":"2008","unstructured":"McCullough P.A.; Agrawal V.; Danielewicz E.; Abela G.S.; Accelerated atherosclerotic calcification and Monckeberg\u2019s sclerosis: a continuum of advanced vascular pathology in chronic kidney disease. Clin J Am Soc Nephrol 2008,3(6),1585-1598","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ki.2008.130","volume":"74","author":"Hruska K.A.","year":"2008","unstructured":"Hruska K.A.; Mathew S.; Lund R.; Qiu P.; Pratt R.; Hyperphosphatemia of chronic kidney disease. Kidney Int 2008,74(2),148-157","journal-title":"Kidney Int"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0140-6736(01)06299-7","volume":"358","author":"Goodman W.G.","year":"2001","unstructured":"Goodman W.G.; Vascular calcification in chronic renal failure. Lancet 2001,358(9288),1115-1116","journal-title":"Lancet"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cccn.2004.08.003","volume":"351","author":"Schurgers L.J.","year":"2005","unstructured":"Schurgers L.J.; Teunissen K.J.; Knapen M.H.; Geusens P.; van der Heijde D.; Kwaijtaal M.; van Diest R.; Ketteler M.; Vermeer C.; Characteristics and performance of an immunosorbent assay for human matrix Gla-protein. Clin Chim Acta 2005,351(1-2),131-138","journal-title":"Clin Chim Acta"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bone.2016.11.012","volume":"100","author":"Yamada S.","year":"2017","unstructured":"Yamada S.; Giachelli C.M.; Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho. Bone 2017,100,87-93","journal-title":"Bone"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1159\/000124863","volume":"45","author":"Cranenburg E.C.","year":"2008","unstructured":"Cranenburg E.C.; Vermeer C.; Koos R.; Boumans M-L.; Hackeng T.M.; Bouwman F.G.; Kwaijtaal M.; Brandenburg V.M.; Ketteler M.; Schurgers L.J.; The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res 2008,45(5),427-436","journal-title":"J Vasc Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1365-2796.2010.02264.x","volume":"268","author":"Ueland T.","year":"2010","unstructured":"Ueland T.; Gullestad L.; Dahl C.P.; Aukrust P.; Aakhus S.; Solberg O.G.; Vermeer C.; Schurgers L.J.; Undercarboxylated matrix Gla protein is associated with indices of heart failure and mortality in symptomatic aortic stenosis. J Intern Med 2010,268(5),483-492","journal-title":"J Intern Med"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1161\/01.ATV.0000245793.83158.06","volume":"26","author":"O\u2019Donnell C.J.","year":"2006","unstructured":"O\u2019Donnell C.J.; Shea M.K.; Price P.A.; Gagnon D.R.; Wilson P.W.; Larson M.G.; Kiel D.P.; Hoffmann U.; Ferencik M.; Clouse M.E.; Williamson M.K.; Cupples L.A.; Dawson-Hughes B.; Booth S.L.; Matrix Gla protein is associated with risk factors for atherosclerosis but not with coronary artery calcification. Arterioscler Thromb Vasc Biol 2006,26(12),2769-2774","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/ndt\/gfv111","volume":"31","author":"Schlieper G.","year":"2016","unstructured":"Schlieper G.; Schurgers L.; Brandenburg V.; Reutelingsperger C.; Floege J.; Vascular calcification in chronic kidney disease: an update. Nephrol Dial Transplant 2016,31(1),31-39","journal-title":"Nephrol Dial Transplant"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1161\/01.ATV.18.9.1400","volume":"18","author":"Price P.A.","year":"1998","unstructured":"Price P.A.; Faus S.A.; Williamson M.K.; Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998,18(9),1400-1407","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1093\/ndt\/gfx258","volume":"33","author":"Wei F-F.","year":"2018","unstructured":"Wei F-F.; Trenson S.; Thijs L.; Huang Q-F.; Zhang Z-Y.; Yang W-Y.; Moliterno P.; Allegaert K.; Boggia J.; Janssens S.; Verhamme P.; Vermeer C.; Staessen J.A.; Desphospho-uncarboxylated matrix Gla protein is a novel circulating biomarker predicting deterioration of renal function in the general population. Nephrol Dial Transplant 2018,33(7),1122-1128","journal-title":"Nephrol Dial Transplant"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000448008","volume":"4","author":"Wei F-F.","year":"2016","unstructured":"Wei F-F.; Drummen N.E.; Thijs L.; Jacobs L.; Herfs M.; Van\u2019t Hoofd C.; Vermeer C.; Staessen J.A.; Vitamin-K-dependent protection of the renal microvasculature: histopathological studies in normal and diseased kidneys. Pulse (Basel) 2016,4(2-3),85-91","journal-title":"Pulse (Basel)"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12020-015-0673-z","volume":"51","author":"Fusaro M.","year":"2016","unstructured":"Fusaro M.; Giannini S.; Gallieni M.; Noale M.; Tripepi G.; Rossini M.; Messa P.; Rigotti P.; Pati T.; Barbisoni F.; Piccoli A.; Aghi A.; Alessi M.; Bonfante L.; Fabris F.; Zambon S.; Sella S.; Iervasi G.; Plebani M.; Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins. Endocrine 2016,51(2),333-341","journal-title":"Endocrine"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.108.783738","volume":"118","author":"Shroff R.C.","year":"2008","unstructured":"Shroff R.C.; McNair R.; Figg N.; Skepper J.N.; Schurgers L.; Gupta A.; Hiorns M.; Donald A.E.; Deanfield J.; Rees L.; Shanahan C.M.; Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008,118(17),1748-1757","journal-title":"Circulation"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"H523","DOI":"10.1152\/ajpheart.00826.2011","volume":"303","author":"Jia G.","year":"2012","unstructured":"Jia G.; Stormont R.M.; Gangahar D.M.; Agrawal D.K.; Role of matrix Gla protein in angiotensin II-induced exacerbation of vascular calcification. Am J Physiol Heart Circ Physiol 2012,303(5),H523-H532","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1161\/01.RES.87.11.1055","volume":"87","author":"Proudfoot D.","year":"2000","unstructured":"Proudfoot D.; Skepper J.N.; Hegyi L.; Bennett M.R.; Shanahan C.M.; Weissberg P.L.; Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000,87(11),1055-1062","journal-title":"Circ Res"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1440-1797.2006.00660.x","volume":"11","author":"Proudfoot D.","year":"2006","unstructured":"Proudfoot D.; Shanahan C.M.; Molecular mechanisms mediating vascular calcification: role of matrix Gla protein. Nephrology (Carlton) 2006,11(5),455-461","journal-title":"Nephrology (Carlton)"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"11400","DOI":"10.1074\/jbc.M116.769802","volume":"292","author":"Marulanda J.","year":"2017","unstructured":"Marulanda J.; Eimar H.; McKee M.D.; Berkvens M.; Nelea V.; Roman H.; Borr\u00e1s T.; Tamimi F.; Ferron M.; Murshed M.; Matrix Gla protein deficiency impairs nasal septum growth, causing midface hypoplasia. J Biol Chem 2017,292(27),11400-11412","journal-title":"J Biol Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/jid.2012.460","volume":"133","author":"Boraldi F.","year":"2013","unstructured":"Boraldi F.; Annovi G.; Vermeer C.; Schurgers L.J.; Trenti T.; Tiozzo R.; Guerra D.; Quaglino D.; Matrix gla protein and alkaline phosphatase are differently modulated in human dermal fibroblasts from PXE patients and controls. J Invest Dermatol 2013,133(4),946-954","journal-title":"J Invest Dermatol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"583","DOI":"10.4103\/0972-124X.119275","volume":"17","author":"Jain A.P.","year":"2013","unstructured":"Jain A.P.; Pundir S.; Sharma A.; Bone morphogenetic proteins: The anomalous molecules. J Indian Soc Periodontol 2013,17(5),583-586","journal-title":"J Indian Soc Periodontol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"G135","DOI":"10.1152\/ajpgi.00482.2005","volume":"291","author":"Beck S.E.","year":"2006","unstructured":"Beck S.E.; Jung B.H.; Fiorino A.; Gomez J.; Rosario E.D.; Cabrera B.L.; Huang S.C.; Chow J.Y.; Carethers J.M.; Bone morphogenetic protein signaling and growth suppression in colon cancer. Am J Physiol Gastrointest Liver Physiol 2006,291(1),G135-G145","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1002\/cncr.25861","volume":"117","author":"Mendelson J.","year":"2011","unstructured":"Mendelson J.; Song S.; Li Y.; Maru D.M.; Mishra B.; Davila M.; Hofstetter W.L.; Mishra L.; Dysfunctional transforming growth factor-\u03b2 signaling with constitutively active Notch signaling in Barrett\u2019s esophageal adenocarcinoma. Cancer 2011,117(16),3691-3702","journal-title":"Cancer"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1172\/JCI116391","volume":"91","author":"Bostr\u00f6m K.","year":"1993","unstructured":"Bostr\u00f6m K.; Watson K.E.; Horn S.; Wortham C.; Herman I.M.; Demer L.L.; Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993,91(4),1800-1809","journal-title":"J Clin Invest"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1161\/hh2401.101070","volume":"89","author":"Steitz S.A.","year":"2001","unstructured":"Steitz S.A.; Speer M.Y.; Curinga G.; Yang H-Y.; Haynes P.; Aebersold R.; Schinke T.; Karsenty G.; Giachelli C.M.; Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 2001,89(12),1147-1154","journal-title":"Circ Res"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"14044","DOI":"10.1074\/jbc.M008103200","volume":"276","author":"Bostr\u00f6m K.","year":"2001","unstructured":"Bostr\u00f6m K.; Tsao D.; Shen S.; Wang Y.; Demer L.L.; Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1\/2 cells. J Biol Chem 2001,276(17),14044-14052","journal-title":"J Biol Chem"},{"key":"ref=100","first-page":"187","volume":"26","author":"T\u00fcys\u00fcz B.","year":"2015","unstructured":"T\u00fcys\u00fcz B.; Cinar B.; La\u00e7iner S.; Onay H.; Mittaz-Crettol L.; Clinical variability in two sisters with keutel syndrome due to a homozygous mutation in mgp gene. Genet Couns 2015,26(2),187-194","journal-title":"Genet Couns"},{"key":"ref=101","first-page":"793-794","volume":"26","author":"Xu L.","year":"2012","unstructured":"Xu L.; Xia Z.; Liu X.; Huang S.; A case of Keutel syndrome in child (review the literature). Lin chuang er bi yan hou tou jing wai ke za zhi 2012,26(18),793-794","journal-title":"Lin chuang er bi yan hou tou jing wai ke za zhi"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00247-013-2768-0","volume":"44","author":"Bosemani T.","year":"2014","unstructured":"Bosemani T.; Felling R.J.; Wyse E.; Pearl M.S.; Tekes A.; Ahn E.; Poretti A.; Huisman T.A.; Neuroimaging findings in children with Keutel syndrome. Pediatr Radiol 2014,44(1),73-78","journal-title":"Pediatr Radiol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"32466","DOI":"10.1074\/jbc.M104909200","volume":"276","author":"Farzaneh-Far A.","year":"2001","unstructured":"Farzaneh-Far A.; Davies J.D.; Braam L.A.; Spronk H.M.; Proudfoot D.; Chan S.W.; O\u2019Shaughnessy K.M.; Weissberg P.L.; Vermeer C.; Shanahan C.M.; A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels. J Biol Chem 2001,276(35),32466-32473","journal-title":"J Biol Chem"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/163778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T04:10:41Z","timestamp":1610251841000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/163778\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,27]]},"references-count":103,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,3,27]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867325666180716104159","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,27]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-04-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}